Loading...
01/09 23:25
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance, particularly in defense systems, and optimistic market strategies. The Q&A highlights growth in health and maritime sectors and opportunities from government initiatives. Despite some vague responses, the overall sentiment is positive with raised margin guidance and a strong backlog. The acquisition aligns with strategic goals, and the share buyback enhances shareholder value. These factors suggest a positive stock price reaction.
Revenue $4.25 billion for Q2 2025, up 3% year-over-year. Growth attributed to ramping contract awards from the second half of 2024 and additional tasking on large franchise programs like DES.
Adjusted EBITDA $647 million for Q2 2025, up 16% year-over-year. Adjusted EBITDA margin increased by 170 basis points to 15.2%. Growth driven by solid execution, efficient operations, and leveraging AI and automation to reduce indirect expenses.
Non-GAAP Diluted EPS $3.21 for Q2 2025, up 22% year-over-year. Growth attributed to improved profitability and favorable one-time items like a $25 million insurance reimbursement and an $8 million tax refund.
Operating Cash Flow $486 million for Q2 2025, up 28% year-over-year. Growth driven by advanced automation in cash flow processes, reducing invoice build and delivery time by almost 40%.
Free Cash Flow $457 million for Q2 2025, with a free cash flow conversion of 110%. Growth supported by strong operating cash flow and efficient capital deployment.
National Security and Digital Revenues Increased 3% year-over-year. Growth driven by ramping contract awards and additional tasking on large franchise programs.
Health and Civil Revenues Increased 1% year-over-year. Sustained performance enabled by high throughput of medical disability exams and focus on innovation.
Commercial International Revenues Increased 1% year-over-year. Growth driven by steady performance in SES, commercial energy business, and improved execution in the U.K. business.
Defense Systems Revenue Increased 10% year-over-year. Growth driven by increased volumes on SDA Wide Field of View Tranche 2 and integrated air defense programs like IFPC Increment 2.
Maritime Autonomy: Leidos is leading in maritime autonomy with its Leidos Autonomous Vessel Architecture (LAVA) and has been contracted by the U.S. Navy and Marines for autonomous vessels like Sea Specter and Sea Dart. The company is also integrating advanced battle management software into maritime systems.
AI Integration: Leidos is leveraging AI to enhance operational efficiency, including proposal writing, cash flow processes, and software development, achieving significant time and cost savings.
North Star 2030 Strategy: Leidos is focusing on five growth pillars: space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services. The company is aligning its operations with government priorities and funding opportunities.
Global Maritime Opportunities: Leidos is targeting a $4 billion pipeline in maritime modernization opportunities, including NATO allies' modernization efforts.
Financial Performance: Leidos achieved record profitability with a 15.2% EBITDA margin and a 28% increase in operating cash flow. The company raised its 2025 guidance and is focusing on efficient operations and leveraging AI to reduce costs.
Contract Wins: Leidos secured significant contracts, including a multibillion-dollar intelligence community contract and opportunities from the Kudu acquisition, adding $400 million in pipeline opportunities.
Acquisitions and Capital Deployment: Leidos completed the Kudu Dynamics acquisition, unlocking $2 billion in near-term opportunities. The company is also focusing on share repurchases and debt paydown.
Government Collaboration: Leidos is positioning itself as a key partner for the government, aligning with the administration's efficiency and innovation agenda.
Dynamic Market Environment: The company is navigating a dynamic market environment, which could pose challenges to maintaining robust revenue growth and profitability.
Regulatory and Administrative Changes: The new administration's efficiency actions and executive orders have created uncertainty, impacting the procurement process and causing delays in contract awards.
Customer Budget Constraints: Customers are focusing on driving down IT costs and consolidating contracts, which could limit revenue growth opportunities.
Dependency on Government Funding: The company's growth pillars and strategic initiatives are heavily reliant on government funding, which could be subject to political and budgetary changes.
Supply Chain and Operational Risks: The company faces risks related to supply chain disruptions and operational challenges, particularly in scaling up production for defense-related projects like Sea Specter and Sea Dart.
Competitive Pressures: The company operates in a highly competitive environment, which could impact its ability to secure new contracts and maintain market share.
Integration Risks: The integration of acquisitions like Kudu Dynamics poses risks, including potential delays or challenges in realizing expected synergies.
Economic Uncertainties: Broader economic uncertainties could impact customer budgets and the overall demand for the company's services.
Revenue Guidance: The company has raised its full-year revenue guidance for 2025 to a range of $17 billion to $17.25 billion, increasing the low end by $100 million and the midpoint by $25 million.
Adjusted EBITDA Margin: Guidance for adjusted EBITDA margin has been raised from the mid- to high 12% range to mid-13%.
Non-GAAP Diluted EPS: The company expects non-GAAP diluted EPS between $11.15 and $11.45, narrowing the range by $0.10 and increasing the midpoint by $0.75.
Operating Cash Flow: Operating cash flow guidance has been raised by $200 million to $1.65 billion, reflecting better EBITDA performance and tax changes allowing immediate deduction of previously capitalized R&D costs.
Maritime Growth Pillar: The U.S. Navy plans to deploy a larger integrated fleet of manned and unmanned vehicles, aligning with Leidos' strengths in maritime autonomy. The fiscal 2025 reconciliation bill allocated robust funding for autonomous vessels and related software. Leidos is positioned to support this expansion with its unmatched maritime capabilities.
AI and Automation: Leidos is leveraging AI and automation to drive efficiencies, including a 20% improvement in proposal writing, a 40% reduction in invoice build time, and a 30% reduction in coding time for software developers. These initiatives are expected to save over 0.5 million labor hours by the end of the fiscal year.
Capital Deployment: The company plans additional share repurchases and debt paydown in the second half of the year, supported by confidence in future cash flows.
Pipeline and Market Opportunities: Leidos has a robust pipeline of opportunities, including a $4 billion maritime modernization pipeline and $2 billion in near-term opportunities from the Kudu acquisition. The company expects a greater awards pace in the second half of the year.
Share Repurchase: During the quarter, Leidos finalized a $500 million accelerated share repurchase on May 20, retiring over 3.6 million shares at an average price of $138.44. The company plans to undertake additional share repurchases during the back half of this year, reflecting confidence in future cash flows and a multifaceted capital deployment philosophy.
The earnings call summary and Q&A highlight several positive factors: raised revenue and EBITDA margin guidance, strong cash flow, and growth in key segments like Defense Systems. The company's strategic focus on AI, automation, and capital deployment, alongside robust pipeline opportunities, further supports a positive outlook. While there are some uncertainties, such as the government shutdown, the overall sentiment is optimistic, suggesting a stock price increase of 2% to 8% over the next two weeks.
The earnings call reveals strong financial performance, particularly in defense systems, and optimistic market strategies. The Q&A highlights growth in health and maritime sectors and opportunities from government initiatives. Despite some vague responses, the overall sentiment is positive with raised margin guidance and a strong backlog. The acquisition aligns with strategic goals, and the share buyback enhances shareholder value. These factors suggest a positive stock price reaction.
The earnings call revealed strong financial performance with a 7% revenue increase and a 30% rise in EPS. The company executed a significant share buyback program and has a robust backlog, indicating future growth. While there are concerns about the Health & Civil segment and some uncertainties in guidance, these are outweighed by the positive financial metrics and strategic initiatives. The market is likely to react positively, with a potential stock price increase of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
